Click on a filter below to refine your search. Remove a filter to broaden your search.
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
An increase of 5.4% is projected per year, and expenditures are set to account for about 20% of GDP in 2031.
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
The authors say that disparities in left ventricular assist device use by race and sex likely are driven by clinician decision-making.